Clinical Development

Venn Life Sciences is a European CRO providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology, medical device and academic organisations. (Image: iStock/RomoloTavani)

Growing CRO eyes further expansion

By Melissa Fassbender

With a new contract signed worth €2.8m ($3.13m), the growing contract research organization (CRO), Venn Life Sciences, is eyeing future expansion.

(Image: iStock)

Medisafe launches commercial offering for pharma

By Melissa Fassbender

Medisafe is launching Medisafe for Pharma after completing several pilots over the past year and a half - one of several new applications that have emerged as the industry focuses on patient centricity.

ABC Laboratories was initially acquired in July 2015. (Image: iStock/Gajus)

ABC Labs unified under newly formed EAG Laboratories

By Melissa Fassbender

The independent lab network has combined 11 of its brands, including ABC Laboratories, to reside under a single company in order to “leverage cross functional capabilities,” says CEO.

(Image: iStock/shironosov)

DIA 2016

endpoint releases new global supply management tool

By Melissa Fassbender

endpoint has introduced its new clinical supply management tool DRIVE, which enables interactive response technology (IRT) functionality for non-IRT and investigator-sponsored trials.

The acquisition is the latest in a series. (Image: iStock)

Charles River acquires analytical CRO

By Melissa Fassbender

Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.

Pfizer has named InVentiv as its fourth preferred partner. (Image: iStock)

Pfizer names inVentiv as 4th CRO

By Melissa Fassbender

After much speculation, inVentiv Health has announced that it has been selected by Pfizer as one of its preferred partners.

The model helps facilitate faster and more efficient enrollment. (Image: iStock/doguhakan)

Frenova launches startup acceleration program

By Melissa Fassbender

Frenova Renal Research has launched its inaugural group of site businesses which comprise F1RST Up – a program designed to accelerate study startup by eliminating common administrative and contracting issues.

The newly launched US group will offer various chemistry, biology, and analytical services. (Image: iStock/eyefocusaz)

British CRO Concept Life Sciences expands into US

By Melissa Fassbender

The expansion is a “natural progression” for the British contract research organization (CRO) who has officially launched its US offering after a successful pilot. 

The state of investment: 'biotech is up'

Dispatches from BIO 2016

The state of investment: 'biotech is up'

By Melissa Fassbender

The biopharmaceutical industry broke several records in 2015 – but to continue the trend will require a sustained investment from multiple stakeholders.

Partners Group plans to work with PCI's management team to add more specialized offerings. (Image: iStock/RomoloTavani)

PCI Pharma Services' new owners focused on growth

By Melissa Fassbender

Partners Group, a private markets investment manager, has agreed to acquire global pharmaceutical services provider PCI Pharma Services citing “trends towards outsourcing.”

Follow us

Products

View more

Webinars